person · Reporting owner
Steeves Richard Martin
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STERIS plcSTE · Entity 3228 | Director | August 08, 2024 | August 12, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STERIS plc
Report date August 08, 2024 · Filed August 12, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $239.68 · Expires 2034-08-08 | Direct | 1,389 |
Reported balance
After 2024-08-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-08-08 · Grant · Acquired 1,389 · Balance 1,389 F1: These nonqualified stock options are fully vested and are exercisable immediately. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $239.68 · Expires 2034-08-08 | Direct | 1,564 |
Reported balance
After 2024-08-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-08-08 · Grant · Acquired 175 · Balance 1,564 F2: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $15,000. F1: These nonqualified stock options are fully vested and are exercisable immediately. |
| Career Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 8,705 |
Reported balance
After 2024-08-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-08-08 · Grant · Acquired 495 · Balance 8,705 F3: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. |
| Career Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,063 |
Reported balance
After 2024-08-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-08-08 · Grant · Acquired 358 · Balance 9,063 F3: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $86,000. F4: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. |
Filing footnotes · ownership attribution and instrument terms
F1: These nonqualified stock options are fully vested and are exercisable immediately.
F2: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $15,000.
F3: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
F4: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
F5: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $86,000.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
STERIS plc
Report date March 28, 2019 · Filed March 28, 2019
Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 1
1 source rowRow 1 · 2019-03-28 · Disposition to issuer · Disposed 9,362 · Balance 0 F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Ordinary Shares,10 pence par valueSEC Table I · non-derivative | IndirectSee Footnote Below. | 0 |
Reported balance
After 2019-03-28 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2019-03-28 · Disposition to issuer · Disposed 319,557 · Balance 0 F2: These ordinary shares are held in a trust. F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Ordinary Shares,10 pence par valueSEC Table I · non-derivative | IndirectSee Footnote Below. | 0 |
Reported balance
After 2019-03-28 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2019-03-28 · Disposition to issuer · Disposed 207,550 · Balance 0 F3: These ordinary shares are held by the reporting person's spouse. F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.40 · Expires 2026-08-10 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-28 · Disposition to issuer · Disposed 3,781 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.23 · Expires 2027-08-09 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-28 · Disposition to issuer · Disposed 4,058 · Balance 0 F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,058 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.74 · Expires 2028-08-09 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-28 · Disposition to issuer · Disposed 436 · Balance 0 F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Career Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-28 · Disposition to issuer · Disposed 3,593 · Balance 0 F7: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,593 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F2: These ordinary shares are held in a trust.
F3: These ordinary shares are held by the reporting person's spouse.
F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,058 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F7: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,593 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 08, 2024 Filed Aug 12, 2024 20:39 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 358 | $239.68 | $85,805.44 |
DisclosureSEC source: 0001628280-24-036803 · wk-form4_1723495134.xml · derivative · entry 4 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,063 Underlying: Ordinary Shares · 358 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $86,000. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:39 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 495 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-036803 · wk-form4_1723495134.xml · derivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,705 Underlying: Ordinary Shares · 495 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:39 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 175 | $85.34 Strike: $239.68 | $14,934.50 |
DisclosureSEC source: 0001628280-24-036803 · wk-form4_1723495134.xml · derivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,564 Underlying: Ordinary Shares · 175 shares Expires 2034-08-08 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $15,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:39 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 1,389 | $0.00 Strike: $239.68 | $0.00 |
DisclosureSEC source: 0001628280-24-036803 · wk-form4_1723495134.xml · derivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,389 Underlying: Ordinary Shares · 1,389 shares Expires 2034-08-08 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 364 | $225.50 | $82,082.00 |
DisclosureSEC source: 0001209191-23-044828 · doc4.xml · derivative · entry 4 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,210 Underlying: Ordinary Shares · 364 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of $82,000 in fees. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044828 · doc4.xml · derivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,846 Underlying: Ordinary Shares · 525 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 195 | $76.72 Strike: $225.50 | $14,960.40 |
DisclosureSEC source: 0001209191-23-044828 · doc4.xml · derivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,740 Underlying: Ordinary Shares · 195 shares Expires 2033-08-03 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $15,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 1,545 | $0.00 Strike: $225.50 | $0.00 |
DisclosureSEC source: 0001209191-23-044828 · doc4.xml · derivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,545 Underlying: Ordinary Shares · 1,545 shares Expires 2033-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:56 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 573 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044588 · doc4.xml · derivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,321 Underlying: Ordinary Shares · 573 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:56 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 241 | $62.32 Strike: $203.00 | $15,019.12 |
DisclosureSEC source: 0001209191-22-044588 · doc4.xml · derivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,110 Underlying: Ordinary Shares · 241 shares Expires 2032-08-03 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $15,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:56 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 1,869 | $0.00 Strike: $203.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044588 · doc4.xml · derivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,869 Underlying: Ordinary Shares · 1,869 shares Expires 2032-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:39 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-051131 · doc4.xml · derivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,748 Underlying: Ordinary Shares · 500 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:39 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 282 | $53.19 Strike: $217.62 | $14,999.58 |
DisclosureSEC source: 0001209191-21-051131 · doc4.xml · derivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,336 Underlying: Ordinary Shares · 282 shares Expires 2021-08-10 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $15,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:39 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 2,054 | $0.00 Strike: $217.62 | $0.00 |
DisclosureSEC source: 0001209191-21-051131 · doc4.xml · derivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,054 Underlying: Ordinary Shares · 2,054 shares Expires 2031-08-10 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:39 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 1,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045485 · doc4.xml · derivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,248 Underlying: Ordinary Shares · 1,316 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| December 06, 2019 Filed Dec 6, 2019 21:27 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 4,279 | $154.27 | $660,121.33 |
DisclosureSEC source: 0001209191-19-059476 · doc4.xml · nonDerivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 0 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $153.78 to $154.54 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held by the reporting person's spouse. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 21:27 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 200 | $153.66 | $30,732.00 |
DisclosureSEC source: 0001209191-19-059476 · doc4.xml · nonDerivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 4,279 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $153.63 to $153.68 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held by the reporting person's spouse. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 21:27 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 5,666 | $153.04 | $867,124.64 |
DisclosureSEC source: 0001209191-19-059476 · doc4.xml · nonDerivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 4,479 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $152.60 to $153.58 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price F2 · ownership.nature: These ordinary shares are held by the reporting person's spouse. Read SEC document |
| December 04, 2019 Filed Dec 4, 2019 21:33 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 5,854 | $153.77 | $900,169.58 |
DisclosureSEC source: 0001209191-19-059067 · doc4.xml · nonDerivative · entry 6 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 10,145 F7 · price: Price reflects a weighted average sale price for multiple transactions ranging from $153.58 to $153.98 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held by the reporting person's spouse. Read SEC document |
| December 03, 2019 Filed Dec 4, 2019 21:33 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 1,200 | $150.85 | $181,020.00 |
DisclosureSEC source: 0001209191-19-059067 · doc4.xml · nonDerivative · entry 5 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 15,999 F6 · price: Price reflects a weighted average sale price for multiple transactions ranging from $150.74 to $150.96 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held by the reporting person's spouse. Read SEC document |
| December 03, 2019 Filed Dec 4, 2019 21:33 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 4,760 | $150.28 | $715,332.80 |
DisclosureSEC source: 0001209191-19-059067 · doc4.xml · nonDerivative · entry 4 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 17,199 F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $149.74 to $150.68 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held by the reporting person's spouse. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:33 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 900 | $151.75 | $136,575.00 |
DisclosureSEC source: 0001209191-19-059067 · doc4.xml · nonDerivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 21,959 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $151.50 to $151.99 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held by the reporting person's spouse. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:33 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 2,800 | $150.97 | $422,716.00 |
DisclosureSEC source: 0001209191-19-059067 · doc4.xml · nonDerivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 22,859 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $150.47 to $151.34 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held by the reporting person's spouse. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:33 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 2,260 | $150.08 | $339,180.80 |
DisclosureSEC source: 0001209191-19-059067 · doc4.xml · nonDerivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 25,659 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $149.44 to $150.39 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price F2 · ownership.nature: These ordinary shares are held by the reporting person's spouse. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 20:39 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 1,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-045125 · doc4.xml · derivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,932 Underlying: Ordinary Shares · 1,339 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 20:39 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 119 | $0.00 Strike: $152.32 | $0.00 |
DisclosureSEC source: 0001209191-19-045125 · doc4.xml · derivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119 Underlying: Ordinary Shares · 119 shares Expires 2029-08-06 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 20:47 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 10,849 | $138.02 | $1,497,378.98 |
DisclosureSEC source: 0001209191-19-036108 · doc4.xml · nonDerivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 0 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $137.76 to $138.25 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 20:47 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 22,644 | $137.36 | $3,110,379.84 |
DisclosureSEC source: 0001209191-19-036108 · doc4.xml · nonDerivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 10,849 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $136.73 to $137.68 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 20:47 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 188,000 | $137.91 | $25,927,080.00 |
DisclosureSEC source: 0001209191-19-036108 · doc4.xml · nonDerivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $137.56 to $138.35 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 21:02 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 2,302 | $137.60 | $316,755.20 |
DisclosureSEC source: 0001209191-19-035849 · doc4.xml · nonDerivative · entry 4 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 33,493 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $137.56 to $137.67 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 21:02 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 53,000 | $136.93 | $7,257,290.00 |
DisclosureSEC source: 0001209191-19-035849 · doc4.xml · nonDerivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 35,795 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $136.56 to $137.55 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 21:02 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 17,565 | $136.24 | $2,393,055.60 |
DisclosureSEC source: 0001209191-19-035849 · doc4.xml · nonDerivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 88,795 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $135.56 to $136.55 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| June 05, 2019 Filed Jun 6, 2019 20:50 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 19,838 | $136.60 | $2,709,870.80 |
DisclosureSEC source: 0001209191-19-035114 · doc4.xml · nonDerivative · entry 5 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 106,360 F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $136.34 to $136.98 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| June 05, 2019 Filed Jun 6, 2019 20:50 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 82,700 | $135.91 | $11,239,757.00 |
DisclosureSEC source: 0001209191-19-035114 · doc4.xml · nonDerivative · entry 4 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 126,198 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $135.34 to $136.33 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 20:50 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 3,659 | $136.07 | $497,880.13 |
DisclosureSEC source: 0001209191-19-035114 · doc4.xml · nonDerivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 208,898 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $136.01 to $136.17 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 20:50 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 107,000 | $135.36 | $14,483,520.00 |
DisclosureSEC source: 0001209191-19-035114 · doc4.xml · nonDerivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 212,557 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $135.00 to $135.99 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:43 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 3,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021609 · doc4.xml · derivative · entry 7 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,593 Underlying: Ordinary Shares · 3,593 shares Expires not disclosed F7 · derivative.exercise_price: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,593 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F7 · derivative.exercise_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,593 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F7 · derivative.expiration_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,593 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:43 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 436 | Not disclosed Strike: $114.74 | Not disclosed |
DisclosureSEC source: 0001209191-19-021609 · doc4.xml · derivative · entry 6 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436 Underlying: Ordinary Shares · 436 shares Expires 2028-08-09 F6 · price: This option to purchase 436 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 436 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option to purchase 436 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 436 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:43 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 4,058 | Not disclosed Strike: $86.23 | Not disclosed |
DisclosureSEC source: 0001209191-19-021609 · doc4.xml · derivative · entry 5 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,058 Underlying: Ordinary Shares · 4,058 shares Expires 2027-08-09 F5 · price: This option to purchase 4,058 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,058 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option to purchase 4,058 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,058 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:43 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 3,781 | Not disclosed Strike: $71.40 | Not disclosed |
DisclosureSEC source: 0001209191-19-021609 · doc4.xml · derivative · entry 4 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,781 Underlying: Ordinary Shares · 3,781 shares Expires 2026-08-10 F4 · price: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:43 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 207,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021609 · doc4.xml · nonDerivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 207,550 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F3 · ownership.nature: These ordinary shares are held by the reporting person's spouse. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:43 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 319,557 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021609 · doc4.xml · nonDerivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 319,557 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F2 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:43 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 9,362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021609 · doc4.xml · nonDerivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,362 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 10:11 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerCareer Restricted Stock Units · Derivative | 3,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021567 · doc4.xml · derivative · entry 7 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,593 shares Expires not disclosed F7 · derivative.exercise_price: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,593 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F7 · derivative.exercise_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,593 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F7 · derivative.expiration_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,593 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 10:11 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 436 | Not disclosed Strike: $114.74 | Not disclosed |
DisclosureSEC source: 0001209191-19-021567 · doc4.xml · derivative · entry 6 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 436 shares Expires 2028-08-09 F6 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F6 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 10:11 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 4,058 | Not disclosed Strike: $86.23 | Not disclosed |
DisclosureSEC source: 0001209191-19-021567 · doc4.xml · derivative · entry 5 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,058 shares Expires 2027-08-09 F5 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,058 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F5 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,058 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 10:11 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 3,781 | Not disclosed Strike: $71.40 | Not disclosed |
DisclosureSEC source: 0001209191-19-021567 · doc4.xml · derivative · entry 4 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,781 shares Expires 2026-08-10 F4 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F4 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 10:11 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerOrdinary Shares,10 pence par value | 207,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021567 · doc4.xml · nonDerivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 0 F3 · shares: These ordinary shares are held by the reporting person's spouse. F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F3 · ownership.nature: These ordinary shares are held by the reporting person's spouse. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 10:11 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerOrdinary Shares,10 pence par value | 319,557 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021567 · doc4.xml · nonDerivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 0 F2 · shares: These ordinary shares are held in a trust. F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F2 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 10:11 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerOrdinary Shares, 10 pence par value | 9,362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021567 · doc4.xml · nonDerivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.